Form D · Private Equity Fund
Sands Capital Life Sciences Pulse Fund III, L.P.
Arlington, VA · CIK 0001981605
Offering snapshot reported Mar 25, 2025 · SEC filing
- Reported sold
- $8M Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 14, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 25, 2025 | Initial | $8,000,000 | No comparison | 1 | SEC filing |
| Jun 15, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06c, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-542119
Source: Form D, filed Mar 25, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan Goodman | Executive |
| Erin Soule | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
C/O Sands Capital Ventures, Llc 1000 Wilson Blvd., Suite 3000
Arlington, VA, 22209
Arlington, VA, 22209